Skip to main content
Erschienen in: Neurocritical Care 1/2016

01.07.2016 | Editorial

Decompressive Hemicraniectomy in the Age of Personalized Medicine

verfasst von: Michael N. Diringer

Erschienen in: Neurocritical Care | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Ever since the pooled analysis of three randomized controlled trials of early decompressive surgery in malignant infarction of the middle cerebral artery was published in 2007 [1], the consideration of decompressive hemicraniectomy for large hemispheric stroke patients has become widespread. That paper reported on the pooled results of three small randomized trials: DECIMAL [2], DESTINY [3], and HAMLET [4]. While the analysis indicated that the procedure clearly can reduce mortality, considerable controversy persists over whether it improves functional outcome. The essence of the dispute is philosophical and essentially can be distilled down to whether one considers a modified Rankin score of four as a good or a bad outcome. …
Literatur
1.
Zurück zum Zitat Vahedi K, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMed Vahedi K, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMed
2.
Zurück zum Zitat Vahedi K, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.CrossRefPubMed Vahedi K, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.CrossRefPubMed
3.
Zurück zum Zitat Juttler E, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRefPubMed Juttler E, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRefPubMed
4.
Zurück zum Zitat Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRefPubMed Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRefPubMed
5.
Zurück zum Zitat Juttler E, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.CrossRefPubMed Juttler E, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.CrossRefPubMed
6.
Zurück zum Zitat Wachter D, et al. Cranioplasty after decompressive hemicraniectomy: underestimated surgery-associated complications? Clin Neurol Neurosurg. 2013;115(8):1293–7.CrossRefPubMed Wachter D, et al. Cranioplasty after decompressive hemicraniectomy: underestimated surgery-associated complications? Clin Neurol Neurosurg. 2013;115(8):1293–7.CrossRefPubMed
7.
Zurück zum Zitat Ewald C, et al. Bone flap necrosis after decompressive hemicraniectomy for malignant middle cerebral artery infarction. Neurocrit Care. 2014;20(1):91–7.CrossRefPubMed Ewald C, et al. Bone flap necrosis after decompressive hemicraniectomy for malignant middle cerebral artery infarction. Neurocrit Care. 2014;20(1):91–7.CrossRefPubMed
8.
9.
Zurück zum Zitat Ong CJ, Keyrouz SG, Diringer MN. The role of osmotic therapy in hemispheric stroke. Neurocrit Care. 2015;23(2):285–91.CrossRefPubMed Ong CJ, Keyrouz SG, Diringer MN. The role of osmotic therapy in hemispheric stroke. Neurocrit Care. 2015;23(2):285–91.CrossRefPubMed
10.
Zurück zum Zitat Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73(9):829–36.CrossRefPubMed Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73(9):829–36.CrossRefPubMed
11.
Zurück zum Zitat Sheth KN, et al. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design. Neurocrit Care. 2016;24(1):132–9.CrossRefPubMed Sheth KN, et al. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design. Neurocrit Care. 2016;24(1):132–9.CrossRefPubMed
Metadaten
Titel
Decompressive Hemicraniectomy in the Age of Personalized Medicine
verfasst von
Michael N. Diringer
Publikationsdatum
01.07.2016
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2016
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0295-1

Weitere Artikel der Ausgabe 1/2016

Neurocritical Care 1/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.